Understanding the gut microbiota in cancer cachexia.

Area of Science:

• Microbiome research
• Cancer biology
• Metabolic syndrome

Background:

• Cachexia, a complex syndrome of weight loss and inflammation, significantly worsens cancer patient prognosis.
• It is associated with reduced treatment tolerance, quality of life, and survival.
• The gut microbiota influences host metabolism and immune responses, suggesting a role in cachexia.

Approach:

• This review synthesizes current evidence on the gut microbiota's role in cancer cachexia development and progression.
• It explores potential underlying mechanisms.
• Promising microbiota-targeted interventions for cachexia are discussed.

Key Points:

• Gut dysbiosis, an imbalance in microbial communities, is implicated in cancer cachexia via muscle wasting, inflammation, and gut barrier dysfunction.
• Interventions like probiotics, prebiotics, synbiotics, and fecal microbiota transplantation show potential in preclinical models.
• Human data supporting these interventions for cancer cachexia remains limited.

Conclusions:

• Further research is essential to elucidate the precise mechanisms connecting gut microbiota and cancer cachexia.
• Human studies are needed to assess the safety, efficacy, and optimal use of microbiome-modulating therapies.
• Understanding these interactions may lead to novel therapeutic strategies for cancer cachexia.